125 related articles for article (PubMed ID: 10556566)
1. Effect of plasminogen activators on human recombinant apolipoprotein(a) having the plasminogen activation cleavage site.
Hervio L; Brunner C; Sorell L; Kang C; Müller H; Anglés-Cano E
Biochim Biophys Acta; 1999 Sep; 1434(1):124-34. PubMed ID: 10556566
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
Anglés-Cano E; Rojas G
Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
[TBL] [Abstract][Full Text] [Related]
3. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).
Ernst A; Helmhold M; Brunner C; Pethö-Schramm A; Armstrong VW; Müller HJ
J Biol Chem; 1995 Mar; 270(11):6227-34. PubMed ID: 7890760
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of fibrinolysis by lipoprotein(a).
Anglés-Cano E; de la Peña Díaz A; Loyau S
Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the proteolytic activity of a recombinant form of apolipoprotein(a).
Gabel BR; Koschinsky MI
Biochemistry; 1995 Dec; 34(48):15777-84. PubMed ID: 7495809
[TBL] [Abstract][Full Text] [Related]
6. A structural assessment of the apo[a] protein of human lipoprotein[a].
Guevara J; Knapp RD; Honda S; Northup SR; Morrisett JD
Proteins; 1992 Feb; 12(2):188-99. PubMed ID: 1318546
[TBL] [Abstract][Full Text] [Related]
7. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL
Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
[TBL] [Abstract][Full Text] [Related]
9. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
[TBL] [Abstract][Full Text] [Related]
10. Substrate kringle-mediated catalysis by the streptokinase-plasmin activator complex: critical contribution of kringle-4 revealed by the mutagenesis approaches.
Joshi KK; Nanda JS; Kumar P; Sahni G
Biochim Biophys Acta; 2012 Feb; 1824(2):326-33. PubMed ID: 22056293
[TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
Rahman MN; Petrounevitch V; Jia Z; Koschinsky ML
Protein Eng; 2001 Jun; 14(6):427-38. PubMed ID: 11477223
[TBL] [Abstract][Full Text] [Related]
12. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.
Eaton DL; Fless GM; Kohr WJ; McLean JW; Xu QT; Miller CG; Lawn RM; Scanu AM
Proc Natl Acad Sci U S A; 1987 May; 84(10):3224-8. PubMed ID: 3472206
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
[TBL] [Abstract][Full Text] [Related]
14. Analysis of structure--function relationships in human apolipoprotein(a).
van der Hoek YY; Kastelein JJ; Koschinsky ML
Can J Physiol Pharmacol; 1994 Mar; 72(3):304-10. PubMed ID: 8069777
[TBL] [Abstract][Full Text] [Related]
15. A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a).
Scanu AM; Pfaffinger D; Lee JC; Hinman J
Biochim Biophys Acta; 1994 Oct; 1227(1-2):41-5. PubMed ID: 7918682
[TBL] [Abstract][Full Text] [Related]
16. Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation.
Sangrar W; Bajzar L; Nesheim ME; Koschinsky ML
Biochemistry; 1995 Apr; 34(15):5151-7. PubMed ID: 7711034
[TBL] [Abstract][Full Text] [Related]
17. Kringles of the plasminogen--prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site.
Dominguez M; Rojas G; Loyau S; Bazurco M; Sorell L; Anglés-Cano E
Biochim Biophys Acta; 2001 Jul; 1548(1):72-80. PubMed ID: 11451440
[TBL] [Abstract][Full Text] [Related]
18. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.
Koschinsky ML; Côté GP; Gabel B; van der Hoek YY
J Biol Chem; 1993 Sep; 268(26):19819-25. PubMed ID: 8366120
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.
Liu L; Boffa MB; Koschinsky ML
PLoS One; 2013; 8(1):e52287. PubMed ID: 23326327
[TBL] [Abstract][Full Text] [Related]
20. Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini-Lp(a) particles and apo(a) fragments.
Edelstein C; Italia JA; Scanu AM
J Biol Chem; 1997 Apr; 272(17):11079-87. PubMed ID: 9111002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
